This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod

기사 요약

Major FDA wins for AstraZeneca: Truqap combination approved for advanced prostate cancer; Ultomiris kidney disease drug gets Priority Review.